Evaluation of Bone Behavior in Maxillary Post-extractive Sites Treated With Guided Bone Regeneration (G.B.R.) Techniques in Alveolar Socket Preservation (A.S.P.) Procedures With Different Autologous and Heterologous Biomaterials.
1 other identifier
interventional
30
1 country
1
Brief Summary
The maxillary bone atrophies from traumatic, pathological events or related to physiological bone loss after tooth extraction, promoting a decrease in bone volume (vertical-horizontal) which has always been a crucial challenge for the clinician in order to obtain adequate rehabilitations prosthetics. The results of bone loss induced aesthetic and functional difficulties in achieving surgical and prosthetic rehabilitation of the right dental implant. Bone loss can be restored with autologous bone grafts and in large bone atrophy of the jaws require complex surgical techniques such as vascularized bone transplantation. As an alternative to the reconstruction of the maxillary tissue, several surgical techniques have been promoted to prevent or minimize bone resorption through market biomaterials with or without the patient's autologous bone. To reduce or counteract biological bone resorption, surgeons have promoted alveolar cavity preservation procedures (ASP) with autologous or heterologous graft materials. Recently, several studies have been published to evaluate the use of demineralized dentin material derived from the extracted tooth to obtain new bone in the maxillary post-extraction site. The aim of the study is to compare different types of biomaterials 4 months after application through the use of the alveolar socket preservation technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jul 2023
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2023
CompletedFirst Submitted
Initial submission to the registry
November 25, 2025
CompletedFirst Posted
Study publicly available on registry
December 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedApril 30, 2026
January 1, 2026
2.8 years
November 25, 2025
April 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of different biomaterials at 4 months to assess the percentage of residual biomaterial remaining in situ and the percentage of newly formed bone in the regenerated area.
4 months after surgery
Study Arms (5)
compare different types of biomaterials 4 months after application through the use of ASP Group 1
ACTIVE COMPARATORcompare different types of biomaterials 4 months after application through the use of ASP Group 2
ACTIVE COMPARATORcompare different types of biomaterials 4 months after application through the use of ASP Group 3
ACTIVE COMPARATORcompare different types of biomaterials 4 months after application through the use of ASP Group 4
ACTIVE COMPARATORcompare different types of biomaterials 4 months after application through the use of ASP Group 5
ACTIVE COMPARATORInterventions
The aim is to compare different types of biomaterials 4 months after application through the use of ASP in Group 1
The aim is to compare different types of biomaterials 4 months after application through the use of ASP in Group 2
The aim is to compare different types of biomaterials 4 months after application through the use of ASP in Group 3
The aim is to compare different types of biomaterials 4 months after application through the use of ASP in Group 4
Eligibility Criteria
You may qualify if:
- Healthy patients.
- Diagnosis of tooth extraction in the upper or lower jaw.
- Preservation procedures necessary to preserve jawbone volume with Guided
- Bone regeneration with autologous or heterologous biomaterials.
You may not qualify if:
- Patients with high risk of receiving the intervention (pre-existing medical conditions/comorbidities/possible adverse events).
- Patients with conditions that may interfere with the evaluation or confound the results. (e.g. they are already taking treatments)
- Patients with refusal to participate, inability to provide data, or at high risk of loss to follow-up.
- Patients with neoplastic pathologies.
- Patients with Radio-Chemo therapies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Foggia
Foggia, Foggia, 71122, Italy
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor, Principal Investigator
Study Record Dates
First Submitted
November 25, 2025
First Posted
December 8, 2025
Study Start
July 3, 2023
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
April 30, 2026
Record last verified: 2026-01